| Bryant Alarcon, | |
|
90 Northern Blvd, Greenvale, NY 11548-1213 | |
| (516) 626-5080 | |
| (516) 626-5081 |
| Full Name | Bryant Alarcon |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 90 Northern Blvd, Greenvale, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275296394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (New York) | Primary |
| Provider Name | Physiologic Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356325799 PECOS PAC ID: 7719974781 Enrollment ID: O20040429001572 |
News Archive
Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.
The Spetzler–Martin grading system is a poor predictor of outcomes of patients with cerebellar arteriovenous malformations, research indicates.
Nationalistic behavior by governments may exclude some countries from gaining access to COVID-19 vaccines and cost the global economy up to $1.2 trillion a year in GDP, according to a new study from the not-for-profit research organization RAND Europe.
Scientists in the Department of Biomedical Engineering at Texas A&M University are developing new ways to advance the field of regenerative medicine and cancer treatment. They are developing a 2D nanosheet that is 1,000 times smaller than a strand of hair.
› Verified 5 days ago
| Provider Name | Achieve At Home Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1932840188 PECOS PAC ID: 4789071903 Enrollment ID: O20220418001858 |
News Archive
Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.
The Spetzler–Martin grading system is a poor predictor of outcomes of patients with cerebellar arteriovenous malformations, research indicates.
Nationalistic behavior by governments may exclude some countries from gaining access to COVID-19 vaccines and cost the global economy up to $1.2 trillion a year in GDP, according to a new study from the not-for-profit research organization RAND Europe.
Scientists in the Department of Biomedical Engineering at Texas A&M University are developing new ways to advance the field of regenerative medicine and cancer treatment. They are developing a 2D nanosheet that is 1,000 times smaller than a strand of hair.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryant Alarcon, 576 Broadhollow Rd, Melville, NY 11747-5002 Ph: (631) 359-5859 | Bryant Alarcon, 90 Northern Blvd, Greenvale, NY 11548-1213 Ph: (516) 626-5080 |
News Archive
Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.
The Spetzler–Martin grading system is a poor predictor of outcomes of patients with cerebellar arteriovenous malformations, research indicates.
Nationalistic behavior by governments may exclude some countries from gaining access to COVID-19 vaccines and cost the global economy up to $1.2 trillion a year in GDP, according to a new study from the not-for-profit research organization RAND Europe.
Scientists in the Department of Biomedical Engineering at Texas A&M University are developing new ways to advance the field of regenerative medicine and cancer treatment. They are developing a 2D nanosheet that is 1,000 times smaller than a strand of hair.
› Verified 5 days ago
Metropolitan Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Forest Dr, Greenvale, NY 11548 Phone: 516-484-1545 Fax: 516-745-6766 | |
Robert Brennan, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 90 Northern Blvd, Unit 6, Greenvale, NY 11548 Phone: 516-626-5080 Fax: 516-626-5081 | |
Samantha Seidita, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 90 Northern Blvd, Greenvale, NY 11548 Phone: 516-626-5080 Fax: 516-626-5081 | |
Kalliope Demas, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 90 Northern Blvd, Greenvale, NY 11548 Phone: 516-626-5080 Fax: 516-626-5081 | |
Athena A Bellmaine, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 90 Northern Blvd, C/o Equinox, Greenvale, NY 11548 Phone: 516-626-5080 Fax: 516-626-5081 | |
Laura Cavalcante, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Northern Blvd, Unit 6, Greenvale, NY 11548 Phone: 516-626-5080 Fax: 516-626-5081 |